Treating Bipolar Disorders

Chapter
Part of the Autism and Child Psychopathology Series book series (ACPS)

Abstract

Bipolar disorder was previously considered only present in adults, but more recently there has been a rise in diagnoses of bipolar disorder in children. Risk factors may include parental factors or comorbid cognitive and behavioral disorders or symptoms. Psychological interventions (e.g., psychoeducational, cognitive behavioral, dialectic behavioral) and psychopharmacological treatments are commonly used to treat children diagnosed with bipolar disorder. Much of the research literature has focused on medication use, which can have significant negative side effects, and additional research on psychological interventions is warranted.

Keywords

Bipolar disorder Risk factors Diagnosis Medication Treatment Children 

References

  1. Azorin, J. M., & Findling, R. L. (2007). Valproate use in children and adolescents with bipolar disorder. CNS Drugs, 21, 1019–1033.CrossRefPubMedGoogle Scholar
  2. American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental disorders (DSM-5). Washington, DC.Google Scholar
  3. Benarous, X., Consoli, A., Milhiet, V., & Cohen, D. (2016). Early interventions for youths at high risk for bipolar disorder: A developmental approach. European Child and Adolescent Psychiatry, 25, 217–233.CrossRefPubMedGoogle Scholar
  4. Benarous, X., Mikita, N., Goodman, R., & Stringaris, A. (2015). Distinct relationships between social aptitude and dimensions of manic-like symptoms in youth. European Child & Adolescent Psychiatry.  https://doi.org/10.1007/s00787-015-0800-7
  5. Betts, K. S., Williams, G. M., Naiman, J. M., & Alati, R. (2016). Predicting spectrums of adult mania, psychosis, and depression by prospectively ascertained childhood neurodevelopment. Journal of Psychiatric Research, 72, 22–29.CrossRefPubMedGoogle Scholar
  6. Biederman, J., Petty, C.R., Wilens, T.E., Spencer, T., Henin, A., Farone, S.V. … Wozniak, J. (2009). Examination of concordance between maternal and youth reports in the diagnosis of pediatric bipolar disorder. Bipolar Disorder, 11, 298–306.Google Scholar
  7. Carlson, G. A., Potegal, M., Margulies, P., Basile, J., & Gutkovich, Z. (2010). Liquid risperidone in the treatment of rages in psychiatrically hospitalized children with possible bipolar disorder. Bipolar Disorders, 12, 205–212.CrossRefPubMedPubMedCentralGoogle Scholar
  8. Chen M-H., Lan, W-H.., Hsu, J-W., Huang, K-L.., Chen, Y-S., Li, C-T. … Bai Y-M.. (2015). Risk of bipolar disorder among adolescents with allergic rhinitis: A nationwide longitudinal study. Journal of Psychosomatic Research, 79, 533–536.Google Scholar
  9. Cotton, S., Luberto, C.M., Sears, R.W., Strawn, J.R., Stahl, L., Wasson, R.S … DelBello, M.P. (2016). Mindfulness-based cognitive therapy for youth with anxiety disorders at risk for bipolar disorder: A pilot trial. Early Intervention in Psychiatry, 10. doi: https://doi.org/10.1111/eip.12216
  10. Detke, H. C., DelBello, M., Landry, J., & Usher, R. W. (2015). Olanzapine/fluoxetine combined in children and adolescents with bipolar I depression: A randomized double-blind placebo-controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry, 54, 217–224.CrossRefPubMedGoogle Scholar
  11. Dickstein, D. P., Cushman, G. K., Kim, K. L., Weissman, A. B., & Wegbreit, E. (2015). Cognitive remediation: Potential novel brain-based treatment for bipolar disorder for children and adolescents. CNS Spectrums, 20, 382–390.CrossRefPubMedPubMedCentralGoogle Scholar
  12. Doey, T. (2012). Aripiprazole in pediatric psychosis and bipolar disorder: A clinical review. Journal of Affective Disorders, 138, 515–521.CrossRefGoogle Scholar
  13. Doucette, S., Horrocks, J., Grof, P., Keown-Stoneman, C., & Duffy, A. (2013). Attachment and temperament profiles among the offspring of a parent with bipolar disorder. Journal of Affective Disorders, 150, 522–526.CrossRefPubMedGoogle Scholar
  14. Duffy, A., Aldo, M., Hajek, T., Sherry, S. B., & Grof, P. (2010). Early stages in the development of bipolar disorder. Journal of Affective Disorders, 121, 127–135.CrossRefPubMedGoogle Scholar
  15. Duffy, A., Jones, S., Goodday, S., & Bentall, R. P. (2015). Candidate risks indicators for bipolar disorder: Early intervention opportunities in high-risk youth. International Journal of Neuropsychopharmacology, 19, pyv071. http://dx.doi.org/10.10931ijnplpyvo71 CrossRefPubMedPubMedCentralGoogle Scholar
  16. Findling, R. L., Correll, C.U., Nyilas, M., Forbes, R.A., McQuade, R.D., Jin, N. … Carlson, G.A. (2013). Aripiprazole for the treatment of pediatric bipolar I disorder: A 30-week, randomized, placebo-controlled study. Bipolar Disorders, 15, 138–149.Google Scholar
  17. Findling, R. L., & Ginsberg, L. D. (2014). The safety and effectiveness of open-label extended-release carbamazepine in the treatment of children and adolescents with bipolar I disorder suffering from a manic or mixed episode. Neuropsychiatric Disease and Treatment, 10, 1589–1597.CrossRefPubMedPubMedCentralGoogle Scholar
  18. Findling, R. L., Kafantaris, V., Pavuluri, M., McNarmara, N. K., Frazier, J. A., Sikich, L., & Taylor-Zapata, P. (2013). Post-acute effectiveness of lithium in pediatric bipolar I disorder. Journal of Child and Adolescent Psychopharmacology, 23, 80–90.CrossRefPubMedPubMedCentralGoogle Scholar
  19. Findling, R. L., Pathak, S., Earley, W. R., Liu, S., & DelBello, M. P. (2014). Efficacy and safety of extended-release quetiapine fumarate in youth with bipolar depression: An 8 week, double-blind placebo-controlled trial. Journal of Child and Adolescent Psychopharmacology, 24, 325–335.CrossRefPubMedPubMedCentralGoogle Scholar
  20. Fristad, M.A., Frazier, T.W., Youngstrom, E.A., Mount, K., Fields, B.W. … Findling, R.L. (2012). What differentiates children visiting outpatient mental health services with bipolar spectrum disorder from children with other psychiatric diagnoses? Bipolar Disorders, 14, 497–506.Google Scholar
  21. Fristad, M.A., Young, A.S., Vesco, A.T., Nader, E.S., Healy, K.Z., Gardner, W … Arnold, L.E. (2015). A randomized controlled trial of individual family psychoeducational psychotherapy and omega-3 fatty acids in youth with subsyndromal bipolar disorder. Journal of Child and Adolescent Psychopharmacology, 25, 764–774.Google Scholar
  22. Geller, B., Luby, J.L., Joshi, P. Wagner, K.D., Emslie, G., Walkup, J. T … Lavori, P. (2012). A randomized controlled trial of risperidone, lithium, or divalproex sodium for initial treatment of bipolar I disorder, manic or mixed phase, in children and adolescents. Archives of General Psychiatry, 69, 515–528.Google Scholar
  23. Goldstein, T.R., Fersch-Podrat, R.K., Rivera, M., Axelson, D.A., Merranko, J., Yu, H … Birmaher, B. (2015). Dialectical behavior therapy for adolescents with bipolar disorder: Results from a pilot randomized trial. Journal of Child and Adolescent Psychopharmacology, 25, 140–149.Google Scholar
  24. Gracious, B. L., Chirieac, M. C., Costescu, S., Youngstrom, E. A., & Hibbeln, J. R. (2010). Randomized, placebo-controlled trial of flax oil in pediatric bipolar disorder. Bipolar Disorders, 12, 142–154.CrossRefPubMedPubMedCentralGoogle Scholar
  25. Haas, M., DelBello, M. P., Pandina, G., Kushner, S., Van Hove, I., Augustyns, I., & Kusumakar, V. (2009). Risperidone for the treatment of acute mania in children and adolescents with bipolar disorder: A randomized, double-blind, placebo-controlled study. Bipolar Disorders, 11, 687–700.CrossRefPubMedGoogle Scholar
  26. Hunt, J., Schwartz, C. M., Nye, P., & Frazier, E. (2016). Is there a bipolar prodromal among children and adolescents? Current Psychiatry Reports, 18, 35.CrossRefPubMedGoogle Scholar
  27. Insel, T. R. (2012). Next generation treatments for mental disorders. Science Translational Medicine, 4, 155ps19.CrossRefPubMedGoogle Scholar
  28. Joshi, G., Petty, C., Wozniak, J., Faraone, S.V., Doyle, R., Georgiopoulos, A … Biederman, J. (2012). A prospective open-label trial of quetiapine monotherapy in preschool and school age children with bipolar spectrum disorder. Journal of Affective Disorder, 136, 1143–1153.Google Scholar
  29. Joshi, G., Wozniak, J., Mick, E., Hammerness, P., Gerogiopoulos, A. … Biederman, J. (2010). A prospective open-label trial of extended-release carbamazepine monotherapy in children with bipolar disorder. Journal of Child and Adolescent Psychopharmacology, 20, 7–14.Google Scholar
  30. Knutsson, J., Backstrom, B., Daukantaite, D., & Lecerof, F. (2016). Adolescent and family-focused cognitive-behavioural therapy for paediatric bipolar disorders: A case series. Clinical Psychology & Psychotherapy.  https://doi.org/10.1002/cpp.2027
  31. Karanti, A., Kardell, M., Lundberg, U., Landén, M. (2016). Changes in mood stabilizer prescription patterns in bipolar disorder. Journal of Affective Disorders, 195, 50–56.Google Scholar
  32. Landersdorfer, C. B., Findling, R. L., Frazier, J. A., Kafantaris, V., & Kirkpatrick, C. M. J. (2016). Lithium in paediatric patients with bipolar disorder: Implications for selection of dosage regimens via population pharmacokinetics/pharmacodynamics. Clinical Pharmacokinetics.  https://doi.org/10.1007/s40262-016-0430-3
  33. Marangoni, C., Hernandez, M., & Faedda, G. L. (2016). The role of environmental exposures as risk factors for bipolar disorder: A systematic review of longitudinal studies. Journal of Affective Disorders, 193, 165–174.CrossRefPubMedGoogle Scholar
  34. Miklouitz, D.J., Schneck, C.D., Singh, M.K., Taylor, D.O., George, E.L., Cosgrove, V.E … Chang, K.D. (2013). Early intervention for symptomatic youth at risk for bipolar disorder: A randomized trial of family-focused therapy. Journal of the American Academy of Child and Adolescent Psychiatry, 52, 121–136.Google Scholar
  35. Miklowitz, D. J., Chang, K. D., Taylor, D. O., George, E. L., Singh, M. K., Schneck, C. D., … & Garber, J. (2011). Early psychosocial intervention for youth at risk for bipolar I or II disorder: A one-year treatment development trial. Bipolar Disorders, 13(1), 67–75.Google Scholar
  36. Naguy, A. (2016). Lithium is clearly underutilized in child psychiatry. Chinese Medical Journal, 129, 376.CrossRefPubMedPubMedCentralGoogle Scholar
  37. Pavuluri, M.N., Henry, D.B., Findling, R.L., Parnes, S., Carbray, J.A., Mohammed, T. … Sweeney, J.A. (2010). Double-blind randomized trial of Risperidone versus Divalproex in pediatric bipolar disorder. Bipolar Disorders, 12, 593–605.Google Scholar
  38. Pavuluri, M. N., Henry, D. B., Moss, M., Mohammed, T., Carbray, J. A., & Sweeney, J. A. (2009). Effectiveness of lamotrigine in maintaining symptom control in pediatric bipolar disorder. Journal of Child and Adolescent Psychopharmacology, 19, 75–82.CrossRefPubMedPubMedCentralGoogle Scholar
  39. Peruzzolo, T. L., Tramontina, S., Rohde, L. A., & Zeni, C. P. (2013). Pharmacotherapy of bipolar disorder in children and adolescents: An update. Revisita Brasileira de Psiquiatria, 35, 393–405.CrossRefGoogle Scholar
  40. Pope, S., & Zaraa, S. G. (2016). Efficacy of long-acting injectable antipsychotics in adolescents. Journal of Child and Adolescent Psychopharmacology, 26, 391–394.CrossRefPubMedGoogle Scholar
  41. Post, R.M., Altshuler, L.L., Kupka, R., McElroy, S.L., Frye, M.A., Rowe, M … Nolen, W.A. (2016). More illness in offspring of bipolar patients from the U.S. compared to Europe. Journal of Affective Disorders, 191, 180–186.Google Scholar
  42. Potter, M. P., Liu, H. Y., Monuteaux, M. C., Henderson, C. S., Wozniak, J., Wilens, T. E., & Biederman, J. (2009). Prescribing patterns for treatment of pediatric bipolar disorders in a specialty clinic. Journal of Child and Adolescent Psychopharmacology, 19, 529–538.CrossRefPubMedPubMedCentralGoogle Scholar
  43. Redden, L., DelBello, M., Wagner, K.D., Wilens, T. E., Malhorta, S., Wozniak, P … Saltarelli, M. (2009). Long-term safety of divalproex sodium extended release in children and adolescents with bipolar I disorder. Journal of Child and Adolescent Psychopharmacology, 19, 83–89.Google Scholar
  44. Ritter, P. S., Marx, C., Lewtschenko, N., Pfeiffer, S., Leopold, K., Bauer, M., & Pfenning, A. (2012). The characteristics of sleep in patients with manifest bipolar disorder, subjects at high risk of developing the disease and health control. Journal of Neural Transmission, 119, 1173–1184.CrossRefPubMedGoogle Scholar
  45. Scheffer, E., Tripathi, A., Kirkpatrick, F. G., & Schultz, T. (2010). Rapid quetiapine loading in youths with bipolar disorder. Journal of Child and Adolescent Psychopharmacology, 20, 441–445.CrossRefPubMedGoogle Scholar
  46. Selten, J.-P., Lundberg, M., Rai, D., & Magnusson, C. (2015). Risk for nonaffective psychotic disorder and bipolar disorder in young people with autism spectrum disorder: A population-based study. JAMA Psychiatry, 72, 483–489.CrossRefPubMedGoogle Scholar
  47. Singh, M. K., Ketter, T. A., & Chang, K. D. (2010). Atypical antipsychotics for acute manic and mixed episodes in children and adolescents with bipolar disorder. Drugs, 70, 433–442.CrossRefPubMedPubMedCentralGoogle Scholar
  48. Stebbins, M. B., & Corcoran, J. (2016). Pediatric bipolar disorder: The child psychiatrist perspective. Child and Adolescent Social Work Journal, 33, 115–122.CrossRefGoogle Scholar
  49. Strawn, J.R., Cotton, S., Luberto, C.M., Patino, R.L., Stahl, L.A., Weber, W.A. … DelBello, M.P. (2016). Neural function before and after mindfulness-based cognitive therapy in anxious adolescents at risk for developing bipolar disorder. Journal of Child and Adolescent Psychopharmacology, 26, 372–379.Google Scholar
  50. Uttley, L., Kearns, B., Ren, S., & Stevenson, M. (2013). Aripiprazole for the treatment and prevention of acute manic and mixed episodes in bipolar I disorder in children and adolescents: A NICE single technology appraisal. PharmacoEconomics, 31, 981–990.CrossRefPubMedGoogle Scholar
  51. Van Meter, A. R., Burke, C., Kowatch, R. A., Findling, R. L., & Youngstrom, E. A. (2016). Ten-year updated meta-analysis of the clinical characteristics of pediatric mania and hypomania. Bipolar Disorders, 18, 19–32.CrossRefPubMedGoogle Scholar
  52. Vande Voort, J. L., Singh, A., Bernardi, J., Wall, C. A., Swintak, C. C., Schak, K. M., & Jensen, P. S. (2016). Treatments and services provided to children diagnosed with bipolar disorder. Child Psychiatry and Human Development, 47, 494–502.CrossRefPubMedGoogle Scholar
  53. Vedel Kessing, L., Vradi, E., & Andersen, P. K. (2015). Diagnostic stability in pediatric bipolar disorder. Journal of Affective Disorders, 172, 417–421.CrossRefPubMedGoogle Scholar
  54. Wong, L.-J., Shyu, Y.-C., Yuan, S.-S., Yang, K.-C., Lee, T.-L., & Lee, S.-Y. (2016). Attention-deficit hyperactivity disorder, its pharmacotherapy and the risk of developing bipolar disorder: A nationwide population-based study in Taiwan. Journal of Psychiatric Research, 72, 6–14.CrossRefGoogle Scholar
  55. Wozniak, J., Faraone, S.V., Chan, J., Tarko, L., Hernandez, M. Davis, J … Biederman, J. (2015). A randomized clinical trial of high eicosapentaenoic acid omega-3 fatty acids and inositol as monotherapy and in combination in the treatment of pediatric bipolar spectrum disorder: A pilot study. The Journal of Clinical Psychiatry, 76, 1548–1555.Google Scholar
  56. Young, A. S., Meers, M. R., Vesco, A. T., Seidenfeld, A. M., Arnold, L. E., & Fristad, M. A. (2016). Predicting therapeutic effects of psychodiagnostic assessment among children and adolescents participating in randomized controlled trials. Journal of Clinical Child and Adolescent Psychology.  https://doi.org/10.1080/15374416.2016.1146992
  57. Youngstrom, E., Zhao, J., Mankoski, R., Forbes, R.A., Marcus, R.M., Carson, W … Findling, R.L. (2013). Clinical significance of treatment effects with aripiprazole versus placebo in a study of manic or mixed episodes associated with pediatric bipolar I disorder. Journal of Child and Adolescent Psychopharmacology, 23, 72–79.Google Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  1. 1.Department of PsychologyLouisiana State UniversityBaton RougeUSA

Personalised recommendations